Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Diabetic patients suffering diabetic foot ulcers (wounds) are benefiting from pioneering efforts in wound therapy. Tissue Regenix, an international medical technology company is leading the development of a range of regenerative products to make specialized replacement tissue using biological (human & animal) materials.
The company offers an expanding roster of products based on their patented dCELL® decellularization technology to provide acellular tissue scaffolds which are not rejected by the patient’s body. DermaPure® is a new decellularized human dermis product from Tissue Regenix used by physicians to help promote wound healing. Initial clinical use has demonstrated that DermaPure® allografts may have scaffold characteristics – including elasticity, porosity and bio-compatibility – comparable to natural tissue, which have been shown to promote beneficial cellular activity during healing.

Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.

Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.

Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.

Comments

comments